ARCHIVES

Groups Urge FDA To Take Action Against Tobacco Products

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For CLL

February 19, 2010

In Brief: NBCC Honors D’Amato, Leahy, Mack, Stevens; Center Development Officers Elect Leaders

May 8, 1998

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

July 30, 2010

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

Data collection Completed In NCI Study of BRACA1

August 16, 1996

Alan Rabson Named NCI Deputy Director

August 11, 1995